PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

106 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮
Lay all publications on this page into basket
1.
Ebert, T.* et al.: Outcomes with finerenone in patients with chronic kidney disease and type 2 diabetes by baseline insulin resistance. Diabetes Care 47, 362-370 (2024)
2.
Ghalwash, M.* et al.: Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles. Diabetes Care 47, 1424-1431 (2024)
3.
Hammersen, J.* et al.: Clinical outcomes in pediatric patients with type 1 diabetes with early versus late diagnosis: Analysis from the DPV registry. Diabetes Care 47, 1808-1817 (2024)
4.
Phillip, M.* et al.: Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 47, 1276-1298 (2024)
5.
von Rauchhaupt, E.* et al.: Glucose load following prolonged fasting increases oxidative stress-linked response in individuals with diabetic complications. Diabetes Care 47, 1584-1592 (2024)
6.
Emmert-Fees, K. et al.: Cost-effectiveness of a collaborative care model among patients with type 2 diabetes and depression in India. Diabetes Care 46, 11-19 (2023)
7.
Frohnert, B.I.* et al.: Refining the definition of stage 1itype 1 diabetes: An ontology-driven analysis of the heterogeneity of multiple Islet autoimmunity. Diabetes Care 46, 1753-1761 (2023)
8.
Liu, X.* et al.: Physical activity and the development of islet autoimmunity and type 1 diabetes in 5-to 15-year-old children followed in the TEDDY study. Diabetes Care 46, 1409-1416 (2023)
9.
Lönnrot, M.* et al.: Gastrointestinal infections modulate the risk for insulin autoantibodies as the first-appearing autoantibody in the TEDDY Study. Diabetes Care 46, 1908-1915 (2023)
10.
Ott, R. et al.: Epigenome-wide meta-analysis reveals associations between dietary glycemic index and glycemic load and DNA methylation in children and adolescents of different body sizes. Diabetes Care 46, 2067-2075 (2023)
11.
Russell, W.E.* et al.: Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: A randomized, double-masked, controlled trial. Diabetes Care 46, 1005-1013 (2023)
12.
Thorsen, S.U.* et al.: Interaction between dietary iron intake and genetically determined iron overload: Risk of islet autoimmunity and progression to Type 1 diabetes in the TEDDY study. Diabetes Care 46, 1014-1018 (2023)
13.
Uusitalo, U.* et al.: HLA genotype and probiotics modify the association between timing of solid food introduction and islet autoimmunity in the TEDDY Study. Diabetes Care 46, 1839-1847 (2023)
14.
Aslam. A.A.* et al.: Diabetes and obesity in down syndrome across the lifespan: A retrospective cohort study using U.K. electronic health records. Diabetes Care 45, 2892–2899 (2022)
15.
Auzanneau, M.* et al.: Frequency of ketoacidosis at diagnosis of pediatric type 1 diabetes associated with socioeconomic deprivation and Uubanization: Results from the German Multicenter DPV Registry. Diabetes Care 45, 1807-1813 (2022)
16.
Heianza, Y.* et al.: Changes in circulating miR-375-3p and improvements in visceral and hepatic fat contents in response to lifestyle interventions: The CENTRAL trial. Diabetes Care 45, 1911-1913 (2022)
17.
Jacobsen, L.M.* et al.: Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45, 624-633 (2022)
18.
Karl, F. ; Winkler, C. ; Ziegler, A.-G. ; Laxy, M. & Achenbach, P.: Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany. Diabetes Care 45, 837-844 (2022)
19.
Krischer, J.P.* et al.: Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: The TEDDY study. Diabetes Care 45, 2271-2281 (2022)
20.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: A randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45, 398-406 (2022)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... ▶▶ ▶▮